Cargando…

Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment

In many cancers, cells undergo re-programming of metabolism, cell survival and anti-apoptotic defense strategies, with the proteins mediating this reprogramming representing potential biomarkers. Here, we searched for novel biomarker proteins in chronic lymphocytic leukemia (CLL) that can impact dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Admoni-Elisha, Lee, Nakdimon, Itay, Shteinfer, Anna, Prezma, Tal, Arif, Tasleem, Arbel, Nir, Melkov, Anna, Zelichov, Ori, Levi, Itai, Shoshan-Barmatz, Varda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831809/ https://www.ncbi.nlm.nih.gov/pubmed/27078856 http://dx.doi.org/10.1371/journal.pone.0148500

Ejemplares similares

VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia
por: Prezma, T, et al.
Publicado: (2013)

Apoptotic proteins with non-apoptotic activity: expression and function in cancer
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2023)

Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2017)

Selective induction of cancer cell death by VDAC1‐based peptides and their potential use in cancer therapy
por: Shteinfer‐Kuzmine, Anna, et al.
Publicado: (2018)

Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States
por: Arif, Tasleem, et al.
Publicado: (2018)

The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link
por: Amsalem, Zohar, et al.
Publicado: (2020)

VDAC1 Silencing in Cancer Cells Leads to Metabolic Reprogramming That Modulates Tumor Microenvironment
por: Zerbib, Erez, et al.
Publicado: (2021)

Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma
por: Shteinfer-Kuzmine, Anna, et al.
Publicado: (2017)

VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2020)

Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells
por: Arif, Tasleem, et al.
Publicado: (2019)

A molecular signature of lung cancer: potential biomarkers for adenocarcinoma and squamous cell carcinoma
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2017)

Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
por: Pandey, Swaroop Kumar, et al.
Publicado: (2022)

Overexpression of the mitochondrial anti-viral signaling protein, MAVS, in cancers is associated with cell survival and inflammation
por: Trishna, Sweta, et al.
Publicado: (2023)

Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo
por: Arif, Tasleem, et al.
Publicado: (2014)

Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo
por: Arif, Tasleem, et al.
Publicado: (2017)

Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2021)

Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks
por: Pandey, Swaroop Kumar, et al.
Publicado: (2022)

Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept
por: Arif, Tasleem, et al.
Publicado: (2019)

SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis
por: Pandey, Swaroop Kumar, et al.
Publicado: (2021)

Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract
por: Nadir, Almog, et al.
Publicado: (2023)

Hypoxic-induced truncation of voltage-dependent anion channel 1 is mediated by both asparagine endopeptidase and calpain 1 activities
por: Pahima, Hadas, et al.
Publicado: (2018)

VDAC1: from structure to cancer therapy
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2012)

Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS
por: Shteinfer-Kuzmine, Anna, et al.
Publicado: (2022)

The Multicellular Effects of VDAC1 N-Terminal-Derived Peptide
por: Anand, Uttpal, et al.
Publicado: (2022)

Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide
por: Pittala, Srinivas, et al.
Publicado: (2018)

VDAC1 and the TSPO: Expression, Interactions, and Associated Functions in Health and Disease States
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2019)

The Mitochondrial Voltage-Dependent Anion Channel 1, Ca(2+) Transport, Apoptosis, and Their Regulation
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2017)

Editorial: Uncovering the Function of the Mitochondrial Protein VDAC in Health and Disease: From Structure-Function to Novel Therapeutic Strategies
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2017)

VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress
por: Shoshan-Barmatz, Varda, et al.
Publicado: (2017)

A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS
por: Shteinfer-Kuzmine, Anna, et al.
Publicado: (2019)

Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
por: Verma, Ankit, et al.
Publicado: (2022)

Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
por: Verma, Ankit, et al.
Publicado: (2023)

Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets
por: Pessoa, João, et al.
Publicado: (2022)

The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus
por: Pittala, Srinivas, et al.
Publicado: (2020)

PTEN Negatively Regulates MAPK Signaling during Caenorhabditis elegans Vulval Development
por: Nakdimon, Itay, et al.
Publicado: (2012)

VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism
por: Klapper-Goldstein, Hadar, et al.
Publicado: (2020)

A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks
por: Zimmerman, Lior, et al.
Publicado: (2020)

SETD3 is a positive regulator of DNA-damage-induced apoptosis
por: Abaev-Schneiderman, Elina, et al.
Publicado: (2019)

International medical leadership, collaboration and communication
por: Arbel, Yael, et al.
Publicado: (2016)

Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS
por: Leyton-Jaimes, Marcel F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0hk2voirspjc6r436skqohbd2v